Why is Artemis Medicare falling/rising?

As of 04-Sep, Artemis Medicare Services Ltd has seen its stock price rise to 227.60, reflecting an increase of 3.1 or 1.38%. Today's performance indicates that the stock has outperformed its sector by 0.51%, reaching an intraday high of Rs 229.1. However, despite this positive movement, the stock has underperformed over the past month with a decline of 8.56% and a year-to-date drop of 27.49%. The company has shown healthy long-term growth, with operating profit increasing at an annual rate of 49.66%, and it has declared positive results for the last six consecutive quarters. Nevertheless, concerns about management efficiency persist, as indicated by a low average return on equity of 8.11%, and a significant portion of promoter shares being pledged, which could exert downward pressure on the stock. In the broader market context, the stock's short-term return of +1.52% over the past week outpaces the Sensex's gain of +0.80%, suggesting a relative strength in the immediate term. However, the stock's performance over the last year has been significantly weaker, with a decline of 16.06% compared to the market's negative return of only 1.98%. This underperformance highlights the challenges faced by Artemis Medicare, despite its recent positive price movement and strong operational metrics. The combination of positive growth indicators and negative management efficiency factors creates a complex picture for investors considering the stock's future trajectory.